Nationwide Recall of Atorvastatin Calcium Tablets Due to Quality Concerns

The U.S. Food and Drug Administration (FDA) has announced a recall affecting over 140,000 bottles of Atorvastatin Calcium Tablets, the generic version of Lipitor, due to "failed dissolution specifications." This recall, initiated by Ascend Laboratories of New Jersey and manufactured by Alkem Laboratories of India, was officially issued on September 19, 2025, and classified as a Class II recall on October 10, 2025. The affected medications may not dissolve properly, potentially reducing their effectiveness in lowering cholesterol and preventing cardiovascular diseases.

Fox Business (website)USA TodayOver 140,000 cholesterol medication bottles recalledAtorvastatin recall: More than 140,000 bottles of cholesterol-lowering drug taken off shelves after FDA warningWKRC - Cincinnati

The recall encompasses various strengths and packaging sizes of Atorvastatin Calcium Tablets, including:

Atorvastatin recall: More than 140,000 bottles of cholesterol-lowering drug taken off shelves after FDA warning

• 10 mg: 90-count, 500-count, and 1,000-count bottles

140,000 Bottles of Cholesterol Medication Recalled: Check Affected Products

• 20 mg: 90-count, 500-count, and 1,000-count bottles

140,000 Bottles of Cholesterol Medication Recalled: Check Affected Products

• 40 mg: 90-count, 500-count, and 1,000-count bottles

140,000 Bottles of Cholesterol Medication Recalled: Check Affected Products

• 80 mg: 90-count and 500-count bottles

140,000 Bottles of Cholesterol Medication Recalled: Check Affected Products

The expiration dates for the recalled products range from July 2026 to February 2027, with specific lot numbers detailed in the FDA's recall database.

USA Today

The FDA's classification of this recall as Class II indicates that while the recalled medications could lead to temporary or medically reversible health consequences, the likelihood of serious adverse effects is considered remote. Atorvastatin is widely prescribed, with approximately 39 million Americans relying on statins for cholesterol management, particularly among adults over 40.

Over 140,000 cholesterol medication bottles recalledUSA TodayFox Business (website)WKRC - CincinnatiAtorvastatin recall: More than 140,000 bottles of cholesterol-lowering drug taken off shelves after FDA warning

Neither Ascend Laboratories nor the FDA has provided specific instructions regarding the disposal of the recalled medications. However, healthcare experts recommend that patients check their medication's lot number against the recalled batches, contact their pharmacy for confirmation, and consult their healthcare provider before making any changes to their medication regimen. Patients should not abruptly discontinue their statin therapy without professional advice, as this could adversely affect their cholesterol management.

Over 140,000 cholesterol medication bottles recalledUSA TodayAtorvastatin recall: More than 140,000 bottles of cholesterol-lowering drug taken off shelves after FDA warningFox Business (website)WKRC - Cincinnati

Concerns have been raised regarding the lack of clear communication from the manufacturers and the FDA about the recall process and what consumers should do with the affected medications. Critics argue that more proactive measures should be taken to ensure patient safety and awareness.

USA Today

• “Regulators have stressed that the likelihood of serious harm is considered low.” — FDA Statement

Atorvastatin recall: More than 140,000 bottles of cholesterol-lowering drug taken off shelves after FDA warning

• “Continuing cholesterol management Patients should not simply stop taking their cholesterol medication without consulting their healthcare provider, even if their specific bottles are part of the recall.” — Healthcare Expert

Over 140,000 cholesterol medication bottles recalled

The recall of Atorvastatin Calcium Tablets highlights the importance of quality control in pharmaceuticals, particularly for medications that millions of Americans depend on for their health. Consumers are urged to remain vigilant, verify their medications, and consult healthcare professionals regarding any concerns related to their cholesterol management.

Over 140,000 cholesterol medication bottles recalledAtorvastatin recall: More than 140,000 bottles of cholesterol-lowering drug taken off shelves after FDA warningWKRC - CincinnatiFox Business (website)